Name: Latest research reports of Divi's Laboratories Ltd. authored by Prabhudas Lilladhar and published by - Trendlyne research reports.
Item: Divi's Laboratories Ltd.
Rating: 1
Author: Prabhudas Lilladhar

Summary	Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report	Discuss
	06 Sep 2025	Divi's Laboratories	Consensus Share Price Target	6009.00	6362.79	-	5.89	hold	pdf Detailed Estimates
	15 Aug 2023	Divi's Laboratories	Prabhudas Lilladhar Reco Target	6009.00	3000.00	3730.55 (61.08%)		Sell	pdf post cache	Broker Report DIVI'S LABORATORIES Prabhudas Lilladhar pdf Copy Link Share on Share on Share on Share on Alert
	15 Aug 2023	Divi's Laboratories	Motilal Oswal Target	6009.00	3430.00	3730.55 (61.08%)	Target met	Neutral	pdf post cache	Broker Report Margin recovers; sales yet to pick up Motilal Oswal pdf Copy Link Share on Share on Share on Share on Alert
	24 May 2023	Divi's Laboratories	Geojit BNP Paribas Target	6009.00	3783.00	3383.15 (77.62%)	Target met	Buy	pdf post cache	Broker Report DIVI' S LAB Geojit BNP Paribas pdf Copy Link Share on Share on Share on Share on Alert
	23 May 2023	Divi's Laboratories	SMC online	6009.00		3385.80 (77.48%)		Results Update	pdf post cache	Broker Report Divis Laboratories SMC online pdf Copy Link Share on Share on Share on Share on Alert
	22 May 2023	Divi's Laboratories	ICICI Securities Limited Target	6009.00	3560.00	3265.00 (84.04%)	Target met	Accumulate	pdf post cache	Broker Report Pricey RM dampens margins; outlook improving ICICI Securities Limited Divi’s Laboratories’ (Divi’s) has posted its highest ever quarterly sales in generics segment of Rs10bn, up 42% YoY in Q4FY23, though a surge in raw material price and overhead cost has impacted margins (down 1,670bps YoY). Management has indicated a gradual improvement in margins Q1FY24 onwards as it has exhausted high-priced inventory and raw material prices are also declining. pdf Copy Link Share on Share on Share on Share on Alert
	22 May 2023	Divi's Laboratories	Motilal Oswal Target	6009.00	2900.00	3265.00 (84.04%)		Neutral	pdf post cache	Broker Report Healthy pick-up in API sales drives earnings Motilal Oswal pdf Copy Link Share on Share on Share on Share on Alert
	21 May 2023	Divi's Laboratories	Prabhudas Lilladhar	6009.00	2700.00	3098.30 (93.95%)		Hold	pdf post cache	Broker Report DIVI'S LABORATORIES Prabhudas Lilladhar pdf Copy Link Share on Share on Share on Share on Alert
	21 May 2023	Divi's Laboratories	ICICI Direct Reco Target	6009.00	3575.00	3098.30 (93.95%)	Target met	Buy	pdf post cache	Broker Report Divi's Laboratories ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
	19 Mar 2023	Divi's Laboratories	Motilal Oswal	6009.00	2620.00	2791.50 (115.26%)		Neutral	pdf post cache	Broker Report Work-in-progress for a better outlook Motilal Oswal pdf Copy Link Share on Share on Share on Share on Alert
	06 Feb 2023	Divi's Laboratories	ICICI Securities Limited Target	6009.00	3024.00	2884.35 (108.33%)	Target met	Hold	pdf post cache	Broker Report Performance weakens, margins shrink ICICI Securities Limited Divi’s Laboratories’ (Divi’s) Q3FY23 performance was well below our estimates. Consolidated revenues fell 7.9% QoQ to Rs17.1bn (I-Sec: Rs20.5bn), EBITDA margin slipped to its lowest-ever at 23.9% (-2,010bps YoY, -960bpsQoQ) pdf Copy Link Share on Share on Share on Share on Alert
more loading

Divi's Laboratories Ltd. share price target

Divi's Laboratories Ltd. has an average share price target of 6414.33. The consensus estimate represents an upside of 6.75% from the last price of 6009. View 9 reports from 6 analysts offering long-term price targets for Divi's Laboratories Ltd..

DIVI'S LABORATORIES

Margin recovers; sales yet to pick up

DIVI' S LAB

Divis Laboratories

Pricey RM dampens margins; outlook improving

Healthy pick-up in API sales drives earnings

DIVI'S LABORATORIES

Divi's Laboratories

Work-in-progress for a better outlook

Performance weakens, margins shrink

Advisor Screeners